Published in Invest Ophthalmol Vis Sci on May 09, 2008
Epithelial membrane protein-2 promotes endometrial tumor formation through activation of FAK and Src. PLoS One (2011) 0.89
Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer. Clin Cancer Res (2010) 0.89
Functional consequences of interactions between FAK and epithelial membrane protein 2 (EMP2). Invest Ophthalmol Vis Sci (2009) 0.89
A novel function of p53: a gatekeeper of retinal detachment. Am J Pathol (2012) 0.87
Loss of Epithelial Membrane Protein 2 Aggravates Podocyte Injury via Upregulation of Caveolin-1. J Am Soc Nephrol (2015) 0.83
Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer. Mol Cancer Ther (2014) 0.83
Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma. J Biol Chem (2014) 0.82
Positron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments. Mol Imaging Biol (2013) 0.82
Epithelial membrane protein-2 (EMP2) and experimental proliferative vitreoretinopathy (PVR). Curr Eye Res (2011) 0.82
EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF. Oncogene (2013) 0.81
Anti-EMP2 diabody blocks epithelial membrane protein 2 (EMP2) and FAK mediated collagen gel contraction in ARPE-19 cells. Exp Eye Res (2012) 0.80
Epithelial membrane protein 2 controls VEGF expression in ARPE-19 cells. Invest Ophthalmol Vis Sci (2013) 0.79
Inhibitory Effect of Bone Morphogenetic Protein 4 in Retinal Pigment Epithelial-Mesenchymal Transition. Sci Rep (2016) 0.76
Rewiring integrin-mediated signaling and cellular response with the peripheral myelin protein 22 and epithelial membrane protein 2 components of the tetraspan web. Invest Ophthalmol Vis Sci (2011) 0.76
Resveratrol inhibits transforming growth factor-β2-induced epithelial-to-mesenchymal transition in human retinal pigment epithelial cells by suppressing the Smad pathway. Drug Des Devel Ther (2017) 0.75
Review of the GAS3 Family of Proteins and their Relevance to Cancer. Crit Rev Oncog (2015) 0.75
Regulation of FAK Activity by Tetraspan Proteins: Potential Clinical Implications in Cancer. Crit Rev Oncog (2015) 0.75
Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes. Invest Ophthalmol Vis Sci (2016) 0.75
Epithelial membrane protein 2 (EMP2) deficiency alters placental angiogenesis, mimicking features of human placental insufficiency. J Pathol (2017) 0.75
The APC tumor suppressor is required for epithelial cell polarization and three-dimensional morphogenesis. Biochim Biophys Acta (2015) 0.75
Versatile retroviral vectors for potential use in gene therapy. Gene Ther (1994) 5.33
Tetraspanins. Cell Mol Life Sci (2001) 3.33
Specific tetraspanin functions. J Cell Biol (2001) 2.35
Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway. J Biol Chem (2004) 2.30
Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling. J Cell Biol (1999) 2.18
Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol (1995) 1.82
Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase. Biochem J (2000) 1.61
Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol (1995) 1.43
Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology. Eye (Lond) (2002) 1.32
Animal models of retinal detachment and reattachment: identifying cellular events that may affect visual recovery. Eye (Lond) (2002) 1.31
Strategies to influence PVR development. Graefes Arch Clin Exp Ophthalmol (2004) 1.30
CD81 expressed on human thymocytes mediates integrin activation and interleukin 2-dependent proliferation. J Exp Med (1996) 1.29
Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (1999) 1.28
Homophilic interactions of Tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways. J Biol Chem (2006) 1.23
Contraction of collagen matrices mediated by alpha2beta1A and alpha(v)beta3 integrins. J Cell Sci (2000) 1.19
Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome. Cancer (2006) 1.18
Role of the alpha 1 beta 1 integrin complex in collagen gel contraction in vitro by fibroblasts. J Cell Physiol (1995) 1.17
Interactions of primary fibroblasts and keratinocytes with extracellular matrix proteins: contribution of alpha2beta1 integrin. J Cell Sci (2006) 1.17
The tetraspan protein epithelial membrane protein-2 interacts with beta1 integrins and regulates adhesion. J Biol Chem (2002) 1.16
Epithelial membrane protein 2, a 4-transmembrane protein that suppresses B-cell lymphoma tumorigenicity. Blood (2001) 1.13
The tetraspan protein EMP2 modulates the surface expression of caveolins and glycosylphosphatidyl inositol-linked proteins. Mol Biol Cell (2004) 1.13
Epithelial membrane protein-2 regulates surface expression of alphavbeta3 integrin in the endometrium. Dev Biol (2005) 1.12
Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity. Cell Immunol (1997) 1.12
Epithelial membrane protein-2 is expressed in discrete anatomical regions of the eye. Exp Mol Pathol (2003) 1.12
Knockdown of the tetraspan protein epithelial membrane protein-2 inhibits implantation in the mouse. Dev Biol (2006) 1.04
The tetraspan protein EMP2 increases surface expression of class I major histocompatibility complex proteins and susceptibility to CTL-mediated cell death. Clin Immunol (2003) 1.04
Collagen gel contraction by ARPE-19 cells is mediated by a FAK-Src dependent pathway. Exp Eye Res (2007) 1.03
Immunolocalization of integrins in proliferative retinal membranes. Invest Ophthalmol Vis Sci (1994) 0.98
Ultrastructural and immunocytochemical changes in retinal pigment epithelium, retinal glia, and fibroblasts in vitreous culture. Invest Ophthalmol Vis Sci (1990) 0.94
Direct binding of F actin to the cytoplasmic domain of the alpha 2 integrin chain in vitro. Biochem Biophys Res Commun (1995) 0.89
Transient activation of the c-Jun N-terminal kinase (JNK) activity by ligation of the tetraspan CD53 antigen in different cell types. Eur J Biochem (2002) 0.88
Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor. Br J Ophthalmol (2000) 0.88
Cytokines and serum cause alpha 2 beta 1 integrin-mediated contraction of collagen gels by cultured retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (1994) 0.86
Differential expression of collagen integrin receptor on fetal vs. adult skin fibroblasts: implication in wound contraction during healing. Br J Dermatol (2002) 0.85
Involvement of rho-kinase pathway in contractile activity of rabbit RPE cells in vivo and in vitro. Invest Ophthalmol Vis Sci (2004) 0.84
Mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K) pathways differently regulate retinal pigment epithelial cell-mediated collagen gel contraction. Exp Eye Res (2005) 0.83
Immunocytology of cellular components in vitreous and subretinal fluid from patients with proliferative vitreoretinopathy. Ophthalmologica (1991) 0.82
Unmet need for mental health care among U.S. children: variation by ethnicity and insurance status. Am J Psychiatry (2002) 5.20
FSH directly regulates bone mass. Cell (2006) 4.64
Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med (2006) 3.59
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med (2012) 3.52
Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J Exp Med (2007) 3.27
Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology (2002) 3.21
Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res (2006) 2.47
Global levels of histone modifications predict prognosis in different cancers. Am J Pathol (2009) 2.28
TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol (2007) 2.17
Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology (2012) 2.11
Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J Clin Invest (2011) 2.09
TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology (2008) 2.06
Intestinal mucosal inflammation leads to systemic genotoxicity in mice. Cancer Res (2009) 1.90
Birdshot chorioretinopathy. Surv Ophthalmol (2005) 1.87
TNFalpha blockade in human diseases: an overview of efficacy and safety. Clin Immunol (2007) 1.85
The need for standardization of antiretinal antibody detection and measurement. Am J Ophthalmol (2008) 1.83
Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroids (2007) 1.80
Lung cancer chemoprevention with celecoxib in former smokers. Cancer Prev Res (Phila) (2011) 1.77
Abundant and diverse fungal microbiota in the murine intestine. Appl Environ Microbiol (2006) 1.76
Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci U S A (2005) 1.71
A model for harmonizing flow cytometry in clinical trials. Nat Immunol (2010) 1.70
The importance of social context: neighborhood stressors, stress-buffering mechanisms, and alcohol, drug, and mental health disorders. Soc Sci Med (2007) 1.68
T-cell responses to survivin in cancer patients undergoing radiation therapy. Clin Cancer Res (2008) 1.61
Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol (2006) 1.60
Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc Natl Acad Sci U S A (2003) 1.60
A system for sharing routine surgical pathology specimens across institutions: the Shared Pathology Informatics Network. Hum Pathol (2007) 1.59
Aromatase inhibitors in human lung cancer therapy. Cancer Res (2005) 1.55
Quality of care for childhood attention-deficit/hyperactivity disorder in a managed care medicaid program. J Am Acad Child Adolesc Psychiatry (2010) 1.55
Disparities in depression treatment for Latinos and site of care. Psychiatr Serv (2005) 1.55
Aromatase expression predicts survival in women with early-stage non small cell lung cancer. Cancer Res (2007) 1.54
Identification of genes differentially expressed in rat alveolar type I cells. Am J Respir Cell Mol Biol (2004) 1.49
Early microbial markers of celiac disease. J Clin Gastroenterol (2014) 1.48
Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. Cancer Res (2004) 1.46
Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. J Clin Invest (2014) 1.45
Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancer. Cancer Res (2010) 1.44
Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma. Clin Cancer Res (2009) 1.43
Commensal microbiota and CD8+ T cells shape the formation of invariant NKT cells. J Immunol (2010) 1.43
Medicare Part D benzodiazepine exclusion and use of psychotropic medication by patients with new anxiety disorders. Psychiatr Serv (2012) 1.42
Ocular manifestations of multiple sclerosis. Curr Opin Ophthalmol (2005) 1.42
Evaluating teaching methods of cataract surgery: validation of an evaluation tool for assessing surgical technique of capsulorhexis. J Cataract Refract Surg (2012) 1.42
Targeting aromatase and estrogen signaling in human non-small cell lung cancer. Ann N Y Acad Sci (2009) 1.39
Expression of transcription factor Yin Yang 1 in prostate cancer. Int J Oncol (2005) 1.37
Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol Rev (2004) 1.34
Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigen. Infect Immun (2002) 1.31
B cell developmental requirement for the G alpha i2 gene. J Immunol (2003) 1.31
Orbital myositis: diagnosis and management. Curr Allergy Asthma Rep (2009) 1.29
Higher levels of GATA3 predict better survival in women with breast cancer. Hum Pathol (2010) 1.28
Quantitation of cell number by a positron emission tomography reporter gene strategy. Mol Imaging Biol (2004) 1.26
Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv Cancer Res (2004) 1.25
Systemic control of plasmacytoid dendritic cells by CD8+ T cells and commensal microbiota. J Immunol (2008) 1.24
COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J (2003) 1.24
Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence. Clin Cancer Res (2007) 1.23
EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer. Cell Metab (2013) 1.23
Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines. Mol Cell Proteomics (2009) 1.19
Bacteria associated with immunoregulatory cells in mice. Appl Environ Microbiol (2009) 1.18
Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome. Cancer (2006) 1.18
The tetraspan protein epithelial membrane protein-2 interacts with beta1 integrins and regulates adhesion. J Biol Chem (2002) 1.16
Differential expression of anterior gradient gene AGR2 in prostate cancer. BMC Cancer (2010) 1.16
Pentraxin-3 is a novel biomarker of lung carcinoma. Clin Cancer Res (2011) 1.15
Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts. Hum Immunol (2006) 1.14
TCR-mediated hyper-responsiveness of autoimmune Galphai2(-/-) mice is an intrinsic naïve CD4(+) T cell disorder selective for the Galphai2 subunit. Int Immunol (2003) 1.13
The tetraspan protein EMP2 modulates the surface expression of caveolins and glycosylphosphatidyl inositol-linked proteins. Mol Biol Cell (2004) 1.13
A metaproteomic approach to study human-microbial ecosystems at the mucosal luminal interface. PLoS One (2011) 1.12
Epithelial membrane protein-2 is expressed in discrete anatomical regions of the eye. Exp Mol Pathol (2003) 1.12
Epithelial membrane protein-2 regulates surface expression of alphavbeta3 integrin in the endometrium. Dev Biol (2005) 1.12
The effects of health sector market factors and vulnerable group membership on access to alcohol, drug, and mental health care. Health Serv Res (2007) 1.11
Monitoring the antitumor response of naive and memory CD8 T cells in RAG1-/- mice by positron-emission tomography. J Immunol (2006) 1.09
Commensal microbiota alter the abundance and TCR responsiveness of splenic naïve CD4+ T lymphocytes. Clin Immunol (2005) 1.09
Frequency of anti-retinal antibodies in normal human serum. J Neuroophthalmol (2008) 1.09
A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma. Clin Cancer Res (2008) 1.08
Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet (2013) 1.07
A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease. PLoS One (2013) 1.06
Formation of B and T cell subsets require the cannabinoid receptor CB2. Immunogenetics (2006) 1.05
RIN1 is a breast tumor suppressor gene. Cancer Res (2007) 1.05
Celecoxib decreases Ki-67 proliferative index in active smokers. Clin Cancer Res (2006) 1.05
Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. Biochem Biophys Res Commun (2005) 1.04
Knockdown of the tetraspan protein epithelial membrane protein-2 inhibits implantation in the mouse. Dev Biol (2006) 1.04
The tetraspan protein EMP2 increases surface expression of class I major histocompatibility complex proteins and susceptibility to CTL-mediated cell death. Clin Immunol (2003) 1.04
Collagen gel contraction by ARPE-19 cells is mediated by a FAK-Src dependent pathway. Exp Eye Res (2007) 1.03
Retinal ganglion cell disorders: types and treatments. Prog Retin Eye Res (2002) 1.02
Activation of autophagy in retinal ganglion cells. J Neurosci Res (2008) 1.00
Improving care for depression in patients with comorbid substance misuse. Am J Psychiatry (2006) 0.99
The tetraspan protein EMP2 regulates expression of caveolin-1. J Biol Chem (2007) 0.99
Resident enteric microbiota and CD8+ T cells shape the abundance of marginal zone B cells. Eur J Immunol (2008) 0.99